Evidence map›Paper›PMID 32641411›Full record

ArticleCancer research2020

Mutant FOXL2

Stine E Weis-Banke, Mads Lerdrup, Daniela Kleine-Kohlbrecher, Faizaan Mohammad, Simone Sidoli, Ole N Jensen, Toshihiko Yanase, Tomoko Nakamura, Akira Iwase, Anthe Stylianou and 9 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Linc-ROR Promotes EMT by Targeting miR-204-5p/SMAD4 in Endometriosis.Reproductive sciences (Thousand Oaks, Calif.) · 2023
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 3 countries.

Stine E Weis-BankeBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen N, Denmark.ORCID 0000-0002-6037-494X
Mads LerdrupCenter for Chromosome Stability, University of Copenhagen, Copenhagen N, Denmark.ORCID 0000-0002-7730-8973
Daniela Kleine-KohlbrecherBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen N, Denmark.
Faizaan MohammadBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen N, Denmark.
Simone SidoliDepartment of Biochemistry and Molecular Biology, VILLUM Centre for Bioanalytical Sciences, University of Southern Denmark, Odense, Denmark.ORCID 0000-0001-9073-6641
Ole N JensenDepartment of Biochemistry and Molecular Biology, VILLUM Centre for Bioanalytical Sciences, University of Southern Denmark, Odense, Denmark.ORCID 0000-0003-1862-8528
Toshihiko YanaseSeiwakai Muta Hospital, 3-9-1 Hoshikuma, Sawara-ku, Fukuoka, Japan.
Tomoko NakamuraDepartments of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Akira IwaseDepartment of Obstetrics and Gynecology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Anthe StylianouDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Nadeem R Abu-RustumDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Carol AghajanianDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Robert SoslowDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Arnaud Da Cruz PaulaDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Richard P KocheCenter for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York.
Britta WeigeltDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Jesper ChristensenBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen N, Denmark.
Kristian HelinBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen N, Denmark. paul.cloos@bric.ku.dk helink@mskcc.org.ORCID 0000-0003-1975-6097
Paul A C CloosBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen N, Denmark. paul.cloos@bric.ku.dk helink@mskcc.org.
Memorial Sloan Kettering Cancer Center · USUniversity of Copenhagen · DKAlbert Einstein College of Medicine · USGunma University · JPMirai Hospital · JPNagoya University · JPUniversity of Southern Denmark · DK

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

The mutant protein FOXL2

Indexed as

Cell Line, TumorCells, CulturedEpithelial-Mesenchymal TransitionFemaleForkhead Box Protein L2Gene Expression Regulation, NeoplasticGranulosa Cell TumorHumansMutationSmad2 ProteinSmad3 ProteinSmad4 ProteinSmad ProteinsForkhead Box Protein L2FOXL2 protein, humanSmad2 ProteinSMAD2 protein, humanSmad3 ProteinSMAD3 protein, humanSmad4 ProteinSMAD4 protein, humanSmad Proteins

Identifiers

PMID32641411
PMCPMC8278322
OpenAlexW3042070952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.